These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11103942)

  • 21. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
    Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
    Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
    Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R
    Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
    Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
    Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
    Bianco R; Shin I; Ritter CA; Yakes FM; Basso A; Rosen N; Tsurutani J; Dennis PA; Mills GB; Arteaga CL
    Oncogene; 2003 May; 22(18):2812-22. PubMed ID: 12743604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
    Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
    Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
    Tsao H; Zhang X; Fowlkes K; Haluska FG
    Cancer Res; 2000 Apr; 60(7):1800-4. PubMed ID: 10766161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
    Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
    Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of multiple drug resistance in human bladder cancer cell lines.
    Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
    J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of PTEN increases sensitivity to SN-38, an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells.
    Saga Y; Mizukami H; Suzuki M; Kohno T; Urabe M; Ozawa K; Sato I
    Clin Cancer Res; 2002 May; 8(5):1248-52. PubMed ID: 12006545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.
    Huang H; Cheville JC; Pan Y; Roche PC; Schmidt LJ; Tindall DJ
    J Biol Chem; 2001 Oct; 276(42):38830-6. PubMed ID: 11495901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways.
    Weng L; Brown J; Eng C
    Hum Mol Genet; 2001 Feb; 10(3):237-42. PubMed ID: 11159942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
    Furnari FB; Huang HJ; Cavenee WK
    Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN/MMAC1 overexpression decreases insulin-like growth factor-I-mediated protection from apoptosis in neuroblastoma cells.
    van Golen CM; Schwab TS; Ignatoski KM; Ethier SP; Feldman EL
    Cell Growth Differ; 2001 Jul; 12(7):371-8. PubMed ID: 11457734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expanding role of PTEN in neoplasia: a molecule for all seasons? Commentary re: M. A. Davies, et al., Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin. Cancer Res., 8: 1904-1914, 2002.
    Fernandez M; Eng C
    Clin Cancer Res; 2002 Jun; 8(6):1695-8. PubMed ID: 12060605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas.
    Zhang P; Steinberg BM
    Cancer Res; 2000 Mar; 60(5):1457-62. PubMed ID: 10728713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.
    Liu J; Babaian DC; Liebert M; Steck PA; Kagan J
    Mol Carcinog; 2000 Nov; 29(3):143-50. PubMed ID: 11108659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.